Biosignatures in thrombotic disorders.
Publication
, Journal Article
Becker, RC
Published in: Journal of thrombosis and thrombolysis
October 2006
Duke Scholars
Published In
Journal of thrombosis and thrombolysis
DOI
EISSN
1573-742X
ISSN
0929-5305
Publication Date
October 2006
Volume
22
Issue
2
Start / End Page
157 / 158
Related Subject Headings
- Ticlopidine
- Thrombosis
- Risk Factors
- Predictive Value of Tests
- Platelet Aggregation Inhibitors
- Patient Selection
- Humans
- Gene Expression Profiling
- Drug Therapy, Combination
- Clopidogrel
Citation
APA
Chicago
ICMJE
MLA
NLM
Becker, R. C. (2006). Biosignatures in thrombotic disorders. Journal of Thrombosis and Thrombolysis, 22(2), 157–158. https://doi.org/10.1007/s11239-006-9404-x
Becker, Richard C. “Biosignatures in thrombotic disorders.” Journal of Thrombosis and Thrombolysis 22, no. 2 (October 2006): 157–58. https://doi.org/10.1007/s11239-006-9404-x.
Becker RC. Biosignatures in thrombotic disorders. Journal of thrombosis and thrombolysis. 2006 Oct;22(2):157–8.
Becker, Richard C. “Biosignatures in thrombotic disorders.” Journal of Thrombosis and Thrombolysis, vol. 22, no. 2, Oct. 2006, pp. 157–58. Epmc, doi:10.1007/s11239-006-9404-x.
Becker RC. Biosignatures in thrombotic disorders. Journal of thrombosis and thrombolysis. 2006 Oct;22(2):157–158.
Published In
Journal of thrombosis and thrombolysis
DOI
EISSN
1573-742X
ISSN
0929-5305
Publication Date
October 2006
Volume
22
Issue
2
Start / End Page
157 / 158
Related Subject Headings
- Ticlopidine
- Thrombosis
- Risk Factors
- Predictive Value of Tests
- Platelet Aggregation Inhibitors
- Patient Selection
- Humans
- Gene Expression Profiling
- Drug Therapy, Combination
- Clopidogrel